Abstract
Background A 61-year-old man with a history of recurrent prostate cancer presented with obstructive urinary symptoms. He had been diagnosed with locally invasive adenocarcinoma of the prostate 10 years previously and treated with neoadjuvant hormonal and external beam radiation therapies. Because of the patient's rising PSA level, he had been started on goserelin 6 years after this diagnosis and bicalutamide 6 months before the current presentation. The patient presented to the urology clinic with worsening lower urinary tract symptoms consisting of nocturia, urgency, and weak stream.
Investigations Physical examination revealed a largely normal digital rectal examination, although there was slight asymmetry. The post-void residual urine volume was approximately 200 ml. Laboratory tests showed no evidence of urinary tract infection, but confirmed a rising PSA level despite low serum testosterone levels. Cystoscopic examination revealed hypervascular, large lateral prostatic lobes obstructing the bladder neck. The bladder was normal.
Diagnosis The patient underwent transurethral resection of the prostate. Soon after the resection started, bilateral papillary tumors arising from the stroma of both prostatic lobes were uncovered. Owing to the diffuse nature of the papillary tumors, complete resection was not possible. Pathologic analysis confirmed the presence of ductal carcinoma of the prostate.
Management The patient had an uneventful postoperative course and reported improvement of voiding symptoms. Staging with bone scan and CT of the abdomen and pelvis demonstrated multi-focal bony metastasis. The patient was started on docetaxel-based chemotherapy for hormone refractory recurrence of prostate cancer as ductal carcinoma of the prostate. He remains under close surveillance for clinical response and progression of disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bostwick DG et al. (1985) Prostatic adenocarcinoma with endometrioid features. Clinical, pathologic, and ultrastructural findings. Am J Surg Pathol 9: 595–609
Eade TN et al. (2007) Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate. Cancer 109: 2011–2015
Brinker DA et al. (1999) Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression. Am J Surg Pathol 23: 1471–1479
Gong Y et al. (2006) Metastatic ductal adenocarcinoma of the prostate: cytologic features and clinical findings. Am J Clin Pathol 126: 302–309
Epstein JI et al. (2006) Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic patholigists. Adv Anat Pathol 13: 57–59
Guo CC et al. (2006) Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance. Mod Pathol 19: 1528–1535
Christensen WN et al. (1991) Prostatic duct adenocarcinoma. Findings at radical prostatectomy. Cancer 67: 2118–2124
Tu SM et al. (2002) Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features. Cancer 94: 2610–2617
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Tu, W., Jensen, K., Freiha, F. et al. A case of prostatic adenocarcinoma recurrence presenting as ductal carcinoma of the prostate. Nat Rev Urol 5, 55–58 (2008). https://doi.org/10.1038/ncpuro0994
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0994
This article is cited by
-
Das duktale Adenokarzinom der Prostata mit Blasenhalsinfiltration
Der Urologe (2009)